{"id": "article-19238_0", "title": "Cervical Intraepithelial Neoplasia -- Continuing Education Activity", "content": "Cervical cancer incidence and mortality have decreased due primarily to screening programs using the pap smear. As more outcome data has become available, screening and treatment guidelines for cervical intraepithelial neoplasia (CIN) have evolved. Detection of the disease in a precancerous state, close monitoring, and treatment are paramount in the prevention of cervical cancer. The screening process for cervical cancer involves pap smear cytology of the cervix along with human papillomavirus (HPV) testing in certain circumstances. This activity reviews the evaluation, treatment, and complications of cervical intraepithelial neoplasia and underscores the importance of an interprofessional team approach to its management.", "contents": "Cervical Intraepithelial Neoplasia -- Continuing Education Activity. Cervical cancer incidence and mortality have decreased due primarily to screening programs using the pap smear. As more outcome data has become available, screening and treatment guidelines for cervical intraepithelial neoplasia (CIN) have evolved. Detection of the disease in a precancerous state, close monitoring, and treatment are paramount in the prevention of cervical cancer. The screening process for cervical cancer involves pap smear cytology of the cervix along with human papillomavirus (HPV) testing in certain circumstances. This activity reviews the evaluation, treatment, and complications of cervical intraepithelial neoplasia and underscores the importance of an interprofessional team approach to its management."}
{"id": "article-19238_1", "title": "Cervical Intraepithelial Neoplasia -- Continuing Education Activity", "content": "Objectives: Describe the epidemiological trends for cervical intraepithelial neoplasia. Review the most commons symptoms associated with cervical intraepithelial neoplasia. Summarize the treatment options for cervical intraepithelial neoplasia. Explain the importance of interprofessional team strategies for improving care coordination and communication to aid in prompt diagnosis of cervical intraepithelial neoplasia and improving outcomes in patients diagnosed with the condition. Access free multiple choice questions on this topic.", "contents": "Cervical Intraepithelial Neoplasia -- Continuing Education Activity. Objectives: Describe the epidemiological trends for cervical intraepithelial neoplasia. Review the most commons symptoms associated with cervical intraepithelial neoplasia. Summarize the treatment options for cervical intraepithelial neoplasia. Explain the importance of interprofessional team strategies for improving care coordination and communication to aid in prompt diagnosis of cervical intraepithelial neoplasia and improving outcomes in patients diagnosed with the condition. Access free multiple choice questions on this topic."}
{"id": "article-19238_2", "title": "Cervical Intraepithelial Neoplasia -- Introduction", "content": "Cervical cancer incidence and mortality have decreased due primarily to screening programs using the pap smear. As more outcome data has become available, screening, and treatment guidelines for cervical intraepithelial neoplasia (CIN) have evolved. Detection of the disease in a precancerous state, close monitoring, and treatment are paramount in the prevention of cervical cancer.\u00a0 The screening process for cervical cancer involves pap smear cytology of the cervix, along with with\u00a0human papillomavirus (HPV) testing in certain circumstances. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Introduction. Cervical cancer incidence and mortality have decreased due primarily to screening programs using the pap smear. As more outcome data has become available, screening, and treatment guidelines for cervical intraepithelial neoplasia (CIN) have evolved. Detection of the disease in a precancerous state, close monitoring, and treatment are paramount in the prevention of cervical cancer.\u00a0 The screening process for cervical cancer involves pap smear cytology of the cervix, along with with\u00a0human papillomavirus (HPV) testing in certain circumstances. [1]"}
{"id": "article-19238_3", "title": "Cervical Intraepithelial Neoplasia -- Etiology", "content": "Human papillomavirus (HPV) infection of the cervix is a sexually transmitted disease and a significant risk factor for the development of cervical intraepithelial neoplasia.\u00a0 However, only a relatively small percentage of women with the infection will develop severe CIN or invasive cervical cancer.\u00a0Several factors determine whether the infection will progress to CIN or carcinoma, the greatest of which is the HPV genotype causing the infection. Although there are approximately 100 subtypes of HPV,\u00a0 a small subgroup has a known association with cervical dysplasia and carcinoma.\u00a0 HPV subtypes are considered either oncogenic or non-oncogenic.\u00a0 Persistence of the virus in tissues is another critical factor in the development of CIN and ultimately, carcinoma. [1] [2] [3] [4]", "contents": "Cervical Intraepithelial Neoplasia -- Etiology. Human papillomavirus (HPV) infection of the cervix is a sexually transmitted disease and a significant risk factor for the development of cervical intraepithelial neoplasia.\u00a0 However, only a relatively small percentage of women with the infection will develop severe CIN or invasive cervical cancer.\u00a0Several factors determine whether the infection will progress to CIN or carcinoma, the greatest of which is the HPV genotype causing the infection. Although there are approximately 100 subtypes of HPV,\u00a0 a small subgroup has a known association with cervical dysplasia and carcinoma.\u00a0 HPV subtypes are considered either oncogenic or non-oncogenic.\u00a0 Persistence of the virus in tissues is another critical factor in the development of CIN and ultimately, carcinoma. [1] [2] [3] [4]"}
{"id": "article-19238_4", "title": "Cervical Intraepithelial Neoplasia -- Etiology", "content": "HPV 16 is the most carcinogenic and accounts for 55 to 60% of cervical cancers worldwide. HPV 18 is the second most carcinogenic and accounts for 10 to 15% of cervical cancer. Risk factors such as smoking, immunocompromised state, or HIV infection\u00a0likely\u00a0lead to persistence of HPV infection and an increased risk for the development of CIN. [5] [6] [7] Although the terminology is changing, cytologic abnormalities on Pap smear\u00a0are typically described as \"squamous intraepithelial lesions\" and further classified as \"low-grade\" or \"high-grade.\"", "contents": "Cervical Intraepithelial Neoplasia -- Etiology. HPV 16 is the most carcinogenic and accounts for 55 to 60% of cervical cancers worldwide. HPV 18 is the second most carcinogenic and accounts for 10 to 15% of cervical cancer. Risk factors such as smoking, immunocompromised state, or HIV infection\u00a0likely\u00a0lead to persistence of HPV infection and an increased risk for the development of CIN. [5] [6] [7] Although the terminology is changing, cytologic abnormalities on Pap smear\u00a0are typically described as \"squamous intraepithelial lesions\" and further classified as \"low-grade\" or \"high-grade.\""}
{"id": "article-19238_5", "title": "Cervical Intraepithelial Neoplasia -- Epidemiology", "content": "HPV infection occurs in sexually active women of any age but is more common in adolescent women and women under the age of 30.\u00a0 The highest incidence is in women ages 20 to 24.\u00a0\u00a0These young women are the most likely to clear the infection to undetectable levels in an average of 8 months; this is the rationale for increasing the initiation of Pap smear screening to age 21. Women over age 30 with HPV detected are more likely to have a persistent infection and warrant more aggressive follow-up to rule out cervical intraepithelial neoplasia. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Epidemiology. HPV infection occurs in sexually active women of any age but is more common in adolescent women and women under the age of 30.\u00a0 The highest incidence is in women ages 20 to 24.\u00a0\u00a0These young women are the most likely to clear the infection to undetectable levels in an average of 8 months; this is the rationale for increasing the initiation of Pap smear screening to age 21. Women over age 30 with HPV detected are more likely to have a persistent infection and warrant more aggressive follow-up to rule out cervical intraepithelial neoplasia. [1]"}
{"id": "article-19238_6", "title": "Cervical Intraepithelial Neoplasia -- Pathophysiology", "content": "Cervical intraepithelial neoplasia results from HPV infection within cervical cells. These changes, especially in young women, commonly revert\u00a0to normal cells due to\u00a0an intact\u00a0immune response and rapid turnover of cells on the cervix. About 60% of CIN-1 will regress\u00a0to normal after 1 year. Women with\u00a0CIN-2\u00a0and CIN-3\u00a0are at high risk for developing invasive cancer, although the average time for progression is still several years. Therefore, women with CIN-2/3 should receive treatment. Exceptions to this recommendation are women in the 20 to 24 year age group and pregnant women.\u00a0 Since a significant percentage of low-grade squamous intraepithelial lesions (LGSIL)\u00a0on Pap smear will have CIN-2 or 3, it makes sense that these pap smears still require colposcopy and biopsy in most cases. The same holds for older women with atypical squamous cells of undetermined significance (ASCUS) pap smears who also have a high-risk HPV.\u00a0Cytology is the screening test, but\u00a0histologic characteristics\u00a0of a tissue biopsy make the diagnosis. [1] [8]", "contents": "Cervical Intraepithelial Neoplasia -- Pathophysiology. Cervical intraepithelial neoplasia results from HPV infection within cervical cells. These changes, especially in young women, commonly revert\u00a0to normal cells due to\u00a0an intact\u00a0immune response and rapid turnover of cells on the cervix. About 60% of CIN-1 will regress\u00a0to normal after 1 year. Women with\u00a0CIN-2\u00a0and CIN-3\u00a0are at high risk for developing invasive cancer, although the average time for progression is still several years. Therefore, women with CIN-2/3 should receive treatment. Exceptions to this recommendation are women in the 20 to 24 year age group and pregnant women.\u00a0 Since a significant percentage of low-grade squamous intraepithelial lesions (LGSIL)\u00a0on Pap smear will have CIN-2 or 3, it makes sense that these pap smears still require colposcopy and biopsy in most cases. The same holds for older women with atypical squamous cells of undetermined significance (ASCUS) pap smears who also have a high-risk HPV.\u00a0Cytology is the screening test, but\u00a0histologic characteristics\u00a0of a tissue biopsy make the diagnosis. [1] [8]"}
{"id": "article-19238_7", "title": "Cervical Intraepithelial Neoplasia -- Histopathology", "content": "The classic microscopic description of HPV infection of cervical epithelial cells is \"koilocytosis.\"\u00a0 This term refers to the appearance of a perinuclear \"halo\" within the cell, along with enlarged and irregular nuclei that show evidence of mitosis. The proportion of cervical epithelium exhibiting dysplastic cells determines the grade of the dysplasia. CIN-1 (low-grade)\u00a0involves the lower 1/3 or less of the epithelium, whereas\u00a0the more significant CIN-2 and CIN-3 (high-grade) progress to\u00a0include the entire thickness of the epithelium.\u00a0 Dysplasia becomes cancer when it invades the basement membrane.", "contents": "Cervical Intraepithelial Neoplasia -- Histopathology. The classic microscopic description of HPV infection of cervical epithelial cells is \"koilocytosis.\"\u00a0 This term refers to the appearance of a perinuclear \"halo\" within the cell, along with enlarged and irregular nuclei that show evidence of mitosis. The proportion of cervical epithelium exhibiting dysplastic cells determines the grade of the dysplasia. CIN-1 (low-grade)\u00a0involves the lower 1/3 or less of the epithelium, whereas\u00a0the more significant CIN-2 and CIN-3 (high-grade) progress to\u00a0include the entire thickness of the epithelium.\u00a0 Dysplasia becomes cancer when it invades the basement membrane."}
{"id": "article-19238_8", "title": "Cervical Intraepithelial Neoplasia -- History and Physical", "content": "In most instances, dysplastic lesions of the cervix are not visible to\u00a0the naked eye, and it is the pap smear which detects abnormalities requiring further evaluation. Some lesions appear as exophytic or plaque-like growths on the cervix.\u00a0 HPV can cause anogenital warts and thus prompt further investigation into other abnormalities caused by HPV.", "contents": "Cervical Intraepithelial Neoplasia -- History and Physical. In most instances, dysplastic lesions of the cervix are not visible to\u00a0the naked eye, and it is the pap smear which detects abnormalities requiring further evaluation. Some lesions appear as exophytic or plaque-like growths on the cervix.\u00a0 HPV can cause anogenital warts and thus prompt further investigation into other abnormalities caused by HPV."}
{"id": "article-19238_9", "title": "Cervical Intraepithelial Neoplasia -- Evaluation", "content": "Colposcopy with directed biopsy is the preferred method for evaluation of an abnormal pap smear result. \"Co-testing\" combines cytology and HPV testing for high-risk types,\u00a0but\u00a0is\u00a0still considered\u00a0screening. The diagnosis ultimately requires\u00a0tissue sampling. There are\u00a0exceptions to this rule:", "contents": "Cervical Intraepithelial Neoplasia -- Evaluation. Colposcopy with directed biopsy is the preferred method for evaluation of an abnormal pap smear result. \"Co-testing\" combines cytology and HPV testing for high-risk types,\u00a0but\u00a0is\u00a0still considered\u00a0screening. The diagnosis ultimately requires\u00a0tissue sampling. There are\u00a0exceptions to this rule:"}
{"id": "article-19238_10", "title": "Cervical Intraepithelial Neoplasia -- Evaluation", "content": "For women aged 21 to 24 with LGSIL cytology because of the high rate of disease resolution,\u00a0repeat cytology at\u00a012-month\u00a0intervals\u00a0is the recommendation.\u00a0 This same age-group of women with Pap smear results showing atypical squamous cells-cannot exclude high grade (ASC-H), atypical glandular cells, or HGSIL results on repeat cytology; colposcopy is the recommendation. For follow-up Pap smears showing ASCUS, LGSIL or negative, the recommendation is to repeat in another 12 months. For those patients with repeated ASCUS or LGSIL at 24 months, colposcopy is the next step. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Evaluation. For women aged 21 to 24 with LGSIL cytology because of the high rate of disease resolution,\u00a0repeat cytology at\u00a012-month\u00a0intervals\u00a0is the recommendation.\u00a0 This same age-group of women with Pap smear results showing atypical squamous cells-cannot exclude high grade (ASC-H), atypical glandular cells, or HGSIL results on repeat cytology; colposcopy is the recommendation. For follow-up Pap smears showing ASCUS, LGSIL or negative, the recommendation is to repeat in another 12 months. For those patients with repeated ASCUS or LGSIL at 24 months, colposcopy is the next step. [1]"}
{"id": "article-19238_11", "title": "Cervical Intraepithelial Neoplasia -- Evaluation", "content": "Patients older than 24 years of age with ASCUS with positive high-risk HPV and LGSIL or higher should undergo colposcopy.\u00a0 \u00a0Regardless of age, women with HGSIL or ASCUS-H should have a colposcopy.\u00a0With a\u00a0diagnosis\u00a0of CIN II or greater,\u00a0excisional treatment is the recommendation.\u00a0 With the subgroup of younger women,\u00a0close observation with colposcopy may be appropriate if they are compliant with care. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Evaluation. Patients older than 24 years of age with ASCUS with positive high-risk HPV and LGSIL or higher should undergo colposcopy.\u00a0 \u00a0Regardless of age, women with HGSIL or ASCUS-H should have a colposcopy.\u00a0With a\u00a0diagnosis\u00a0of CIN II or greater,\u00a0excisional treatment is the recommendation.\u00a0 With the subgroup of younger women,\u00a0close observation with colposcopy may be appropriate if they are compliant with care. [1]"}
{"id": "article-19238_12", "title": "Cervical Intraepithelial Neoplasia -- Treatment / Management", "content": "CIN-1 can undergo observation and co-testing repeated in 1 year. If CIN-1 is persistent after 2 years or progresses within that time,\u00a0treatment is the recommendation. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Treatment / Management. CIN-1 can undergo observation and co-testing repeated in 1 year. If CIN-1 is persistent after 2 years or progresses within that time,\u00a0treatment is the recommendation. [1]"}
{"id": "article-19238_13", "title": "Cervical Intraepithelial Neoplasia -- Treatment / Management", "content": "As stated earlier, CIN -2 or higher requires treatment. Treatment is also recommended when there is more than one degree of\u00a0difference between pap results and biopsy results. For example, if the pap smear is high-grade intraepithelial lesion (HGSIL), but the biopsy is negative, the potential reasons are a misread of the specimen, or there was a missed a lesion at the time of colposcopy. In this case, a diagnostic excisional procedure\u00a0is the preferred mode of treatment because it is both therapeutic and diagnostic. The margins of the cervical specimen\u00a0may then undergo evaluation for complete removal of any abnormal cells. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Treatment / Management. As stated earlier, CIN -2 or higher requires treatment. Treatment is also recommended when there is more than one degree of\u00a0difference between pap results and biopsy results. For example, if the pap smear is high-grade intraepithelial lesion (HGSIL), but the biopsy is negative, the potential reasons are a misread of the specimen, or there was a missed a lesion at the time of colposcopy. In this case, a diagnostic excisional procedure\u00a0is the preferred mode of treatment because it is both therapeutic and diagnostic. The margins of the cervical specimen\u00a0may then undergo evaluation for complete removal of any abnormal cells. [1]"}
{"id": "article-19238_14", "title": "Cervical Intraepithelial Neoplasia -- Treatment / Management", "content": "The usual treatment is via ablation or excision of abnormal cells. Ablation of abnormal cells includes cryosurgery or laser ablation (CO2 laser). Ablation is only acceptable when the endocervical sampling is negative, there are no glandular abnormalities, the entire borders of the lesion are visible, and the patient has not failed other treatments. These techniques were more common before the development of LEEP (loop electrosurgical excision procedure). Ablative procedures have a higher recurrence rate in the setting of severe dysplasia when compared to LEEP. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Treatment / Management. The usual treatment is via ablation or excision of abnormal cells. Ablation of abnormal cells includes cryosurgery or laser ablation (CO2 laser). Ablation is only acceptable when the endocervical sampling is negative, there are no glandular abnormalities, the entire borders of the lesion are visible, and the patient has not failed other treatments. These techniques were more common before the development of LEEP (loop electrosurgical excision procedure). Ablative procedures have a higher recurrence rate in the setting of severe dysplasia when compared to LEEP. [1]"}
{"id": "article-19238_15", "title": "Cervical Intraepithelial Neoplasia -- Treatment / Management", "content": "Excisional procedures for the treatment of CIN include LEEP, cold knife conization, and laser conization. Whether any of these procedures increase a patient\u2019s risk for preterm labor is controversial since the risks for preterm delivery and dysplasia overlap considerably. That said, in women younger than 25 with CIN-2 or 3, there may be a role for close observation with colposcopy in 6 months rather than excision.\u00a0 However, that is not the currently preferred treatment option. During pregnancy, treatment is postponed until after delivery unless colposcopic surveillance during pregnancy reveals progression to invasive cervical cancer. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Treatment / Management. Excisional procedures for the treatment of CIN include LEEP, cold knife conization, and laser conization. Whether any of these procedures increase a patient\u2019s risk for preterm labor is controversial since the risks for preterm delivery and dysplasia overlap considerably. That said, in women younger than 25 with CIN-2 or 3, there may be a role for close observation with colposcopy in 6 months rather than excision.\u00a0 However, that is not the currently preferred treatment option. During pregnancy, treatment is postponed until after delivery unless colposcopic surveillance during pregnancy reveals progression to invasive cervical cancer. [1]"}
{"id": "article-19238_16", "title": "Cervical Intraepithelial Neoplasia -- Treatment / Management", "content": "Women treated for CIN-2, or greater should have a Pap smear and HPV testing 12 and 24 months after the procedure. Even with positive endocervical margins on an excised specimen, the procedure is deemed 70 to 80% effective. When margins are positive, repeat cytology testing in\u00a04-6 months accompanied by an endocervical curettage is the course of action.\u00a0 A repeat excisional procedure is one option for treatment of persistent or recurrent CIN-2 or 3. In some circumstances, patients will opt for a hysterectomy, which is also appropriate for recurrent CIN. [1]", "contents": "Cervical Intraepithelial Neoplasia -- Treatment / Management. Women treated for CIN-2, or greater should have a Pap smear and HPV testing 12 and 24 months after the procedure. Even with positive endocervical margins on an excised specimen, the procedure is deemed 70 to 80% effective. When margins are positive, repeat cytology testing in\u00a04-6 months accompanied by an endocervical curettage is the course of action.\u00a0 A repeat excisional procedure is one option for treatment of persistent or recurrent CIN-2 or 3. In some circumstances, patients will opt for a hysterectomy, which is also appropriate for recurrent CIN. [1]"}
{"id": "article-19238_17", "title": "Cervical Intraepithelial Neoplasia -- Differential Diagnosis", "content": "The differential diagnosis should include normal squamous cells, cervical warty lesions, inflammation, infection, and carcinoma.", "contents": "Cervical Intraepithelial Neoplasia -- Differential Diagnosis. The differential diagnosis should include normal squamous cells, cervical warty lesions, inflammation, infection, and carcinoma."}
{"id": "article-19238_18", "title": "Cervical Intraepithelial Neoplasia -- Prognosis", "content": "The prognosis for cervical intraepithelial neoplasia differs depending on the severity. With adherence to ASCCP guidelines, the risk for progression to carcinoma is low. The risk of overt cervical cancer is significantly higher when a woman has missed screening for more than 10 years.", "contents": "Cervical Intraepithelial Neoplasia -- Prognosis. The prognosis for cervical intraepithelial neoplasia differs depending on the severity. With adherence to ASCCP guidelines, the risk for progression to carcinoma is low. The risk of overt cervical cancer is significantly higher when a woman has missed screening for more than 10 years."}
{"id": "article-19238_19", "title": "Cervical Intraepithelial Neoplasia -- Complications", "content": "Complications can arise from cervical biopsy include excessive bleeding or infection, but are rare. Surgical treatments such as a cold knife cone or LEEP carry increased\u00a0risks, including risks of anesthesia. In\u00a0those individuals treated with an excisional procedure, there have been concerns regarding the risk of pregnancy complications such as preterm delivery or cervical incompetence.\u00a0 However, the risk factors for these complications overlap\u00a0those for cervical dysplasia, so\u00a0it is difficult to discern the actual impact of the excisional procedure on preterm delivery. [9] [10]", "contents": "Cervical Intraepithelial Neoplasia -- Complications. Complications can arise from cervical biopsy include excessive bleeding or infection, but are rare. Surgical treatments such as a cold knife cone or LEEP carry increased\u00a0risks, including risks of anesthesia. In\u00a0those individuals treated with an excisional procedure, there have been concerns regarding the risk of pregnancy complications such as preterm delivery or cervical incompetence.\u00a0 However, the risk factors for these complications overlap\u00a0those for cervical dysplasia, so\u00a0it is difficult to discern the actual impact of the excisional procedure on preterm delivery. [9] [10]"}
{"id": "article-19238_20", "title": "Cervical Intraepithelial Neoplasia -- Pearls and Other Issues", "content": "The American Society for Colposcopy and Cervical Pathology (ASCCP) has published a smartphone application entitled \u201cASSCP Mobile\u201d\u00a0that is updated regularly. It has a user-friendly algorithm for screening guidelines and management recommendations.\u00a0 It is available for Android and IOS platforms for a minimal fee.", "contents": "Cervical Intraepithelial Neoplasia -- Pearls and Other Issues. The American Society for Colposcopy and Cervical Pathology (ASCCP) has published a smartphone application entitled \u201cASSCP Mobile\u201d\u00a0that is updated regularly. It has a user-friendly algorithm for screening guidelines and management recommendations.\u00a0 It is available for Android and IOS platforms for a minimal fee."}
{"id": "article-19238_21", "title": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes", "content": "Healthcare providers, including the nurse practitioner, should discuss cervical cancer screening protocols and implement a reliable system for follow up, especially for abnormal results.\u00a0 This system should include a combination of verbal and written notifications about the process of evaluation and the importance of appropriate\u00a0follow-up.", "contents": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes. Healthcare providers, including the nurse practitioner, should discuss cervical cancer screening protocols and implement a reliable system for follow up, especially for abnormal results.\u00a0 This system should include a combination of verbal and written notifications about the process of evaluation and the importance of appropriate\u00a0follow-up."}
{"id": "article-19238_22", "title": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes", "content": "Consistent condom use is among the most effective methods for women to protect themselves from HPV transmission.\u00a0 HPV vaccines also protect against HPV-related diseases. [11] They are FDA approved and show nearly 100% efficacy in preventing cervical neoplasia from HPV subtypes included in the vaccine. These vaccines provide immunity for several subtypes of HPV. All women should receive cervical cancer screening per ASCCP guidelines, regardless of their HPV immunization status.", "contents": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes. Consistent condom use is among the most effective methods for women to protect themselves from HPV transmission.\u00a0 HPV vaccines also protect against HPV-related diseases. [11] They are FDA approved and show nearly 100% efficacy in preventing cervical neoplasia from HPV subtypes included in the vaccine. These vaccines provide immunity for several subtypes of HPV. All women should receive cervical cancer screening per ASCCP guidelines, regardless of their HPV immunization status."}
{"id": "article-19238_23", "title": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes", "content": "Cervical intraepithelial neoplasia requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, all collaborating across disciplines to achieve optimal patient results. [Level V]", "contents": "Cervical Intraepithelial Neoplasia -- Enhancing Healthcare Team Outcomes. Cervical intraepithelial neoplasia requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, all collaborating across disciplines to achieve optimal patient results. [Level V]"}
{"id": "article-19238_24", "title": "Cervical Intraepithelial Neoplasia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cervical Intraepithelial Neoplasia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}